Skip to main content
Premium Trial:

Request an Annual Quote

Daltonics/AXS Merger Boosts Bruker s Q4 Revenues

NEW YORK, March 2 (GenomeWeb News) - Bruker BioSciences today reported in increase in its fourth-quarter earnings year-over-year following the July 2003 merger of Bruker Daltonics and Bruker AXS.

For the fourth quarter of 2003, Bruker BioSciences posted revenues of $73.7 million, up 18 percent from the previously separate companies' combined revenues of $62.5 million for the fourth quarter of 2002. After eliminating $9.2 million in currency effects, however, Bruker's fourth-quarter 2003 revenue increased only 3 percent year-over-year, the company said.

Revenue for the Bruker Daltonics business increased to $42.0 million, from $32.9 million in the fourth quarter of 2002; while revenues for the Bruker AXS business increased to $31.7 million, compared to $29.6 million in the fourth quarter of 2002.

In the fourth quarter of 2003, Bruker reported GAAP net income of $300,000, compared to a combined net loss of $4.9 million for Bruker Daltonics and Bruker AXS in the year-ago period.

Bruker spent $9.9 million on R&D during the fourth quarter of 2003, an 18 percent increase over its Q4 2002 R&D spending of $8.4 million.

 

The company had $76.8 million in cash and short-term investments on hand as of Dec. 31, 2003, compared to $9.6 million at the close of 2002.

Bruker said it anticipates 13-15 percent revenue growth in 2004, with revenues for the year in the range of $290 million to $300 million.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.